ELECTROCORE INC
ECORNASDAQ🏆 #4140 by market capUS Equity
——
Quote unavailableTrack ECOR
Get earnings, price moves & breaking news on Telegram
24h—
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$70M
Small Cap
📈Revenue Growth (YoY)
33.5%
High Growth
📊Gross Margin
87.5%
High
💵FCF Margin
—
⚖️P/S Ratio
1.9x
Cheap
Otter Score
—
Insufficient data
No chart data available for ECOR.
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $4.41 – $12.70
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 9.0M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- —
- Last Q Revenue
- —
- P/E Ratio
- —
- P/S Ratio
- 1.9x
- EPS (TTM)
- $-1.66
- Dividend Yield
- —
ELECTROCORE INC
ECORFinancial Trends
Financial history unavailable.
StockOtter · stockotter.spaceAbout ELECTROCORE INC
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.